Myeloablative Intravenous Pharmacokinetically Targeted Busulfan Plus Fludarabine As Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients With Non-Hodgkin Lymphoma
- Resource Type
- Article
- Source
- In
Clinical Lymphoma Myeloma and Leukemia June 2015 15(6):335-340 - Subject
- Language
- ISSN
- 2152-2650